NZ572680A - Cladribine and interferon-beta regimen for treating multiple sclerosis - Google Patents

Cladribine and interferon-beta regimen for treating multiple sclerosis

Info

Publication number
NZ572680A
NZ572680A NZ572680A NZ57268007A NZ572680A NZ 572680 A NZ572680 A NZ 572680A NZ 572680 A NZ572680 A NZ 572680A NZ 57268007 A NZ57268007 A NZ 57268007A NZ 572680 A NZ572680 A NZ 572680A
Authority
NZ
New Zealand
Prior art keywords
cladribine
period
months
duration
administered
Prior art date
Application number
NZ572680A
Other languages
English (en)
Inventor
H Brentzel
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Priority claimed from PCT/EP2007/055013 external-priority patent/WO2007135172A2/en
Publication of NZ572680A publication Critical patent/NZ572680A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ572680A 2006-05-24 2007-05-23 Cladribine and interferon-beta regimen for treating multiple sclerosis NZ572680A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114537 2006-05-24
US84547006P 2006-09-18 2006-09-18
PCT/EP2007/055013 WO2007135172A2 (en) 2006-05-24 2007-05-23 Cladribine regimen for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
NZ572680A true NZ572680A (en) 2011-11-25

Family

ID=37395884

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ572680A NZ572680A (en) 2006-05-24 2007-05-23 Cladribine and interferon-beta regimen for treating multiple sclerosis

Country Status (12)

Country Link
CN (1) CN101500598A (ru)
AT (1) ATE555804T1 (ru)
BR (1) BRPI0710326A2 (ru)
DK (1) DK2026832T3 (ru)
EC (1) ECSP088997A (ru)
ES (1) ES2384399T3 (ru)
MY (1) MY149042A (ru)
NZ (1) NZ572680A (ru)
PT (1) PT2026832E (ru)
RS (1) RS52424B (ru)
SI (1) SI2026832T1 (ru)
UA (1) UA96941C2 (ru)

Also Published As

Publication number Publication date
UA96941C2 (ru) 2011-12-26
SI2026832T1 (sl) 2012-07-31
ATE555804T1 (de) 2012-05-15
MY149042A (en) 2013-07-15
CN101500598A (zh) 2009-08-05
BRPI0710326A2 (pt) 2011-08-09
RS52424B (en) 2013-02-28
DK2026832T3 (da) 2012-06-25
PT2026832E (pt) 2012-06-01
ES2384399T3 (es) 2012-07-04
ECSP088997A (es) 2009-01-30

Similar Documents

Publication Publication Date Title
US10555913B2 (en) Cladribine regimen for treating multiple sclerosis
AU2011200768B2 (en) Cladribine regimen for treating multiple sclerosis
AU2006286489B2 (en) Treatment of optic neuritis
NZ572680A (en) Cladribine and interferon-beta regimen for treating multiple sclerosis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 23 MAY 2017 BY CPA GLOBAL

Effective date: 20140410

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2018 BY CPA GLOBAL

Effective date: 20170407

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2019 BY CPA GLOBAL

Effective date: 20180405

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2020 BY CPA GLOBAL

Effective date: 20190411

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2021 BY CPA GLOBAL

Effective date: 20200410

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2022 BY CPA GLOBAL

Effective date: 20210408

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2023 BY CPA GLOBAL

Effective date: 20220407

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAY 2024 BY CPA GLOBAL

Effective date: 20230406